{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6737294eba4404855a7b37bb/6a9e7a31ffe0e274912d0b85?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Episode 10: From results to action making every test count  ","description":"<p>In this episode, Dr. Luke Moore and Prof. Maria Virginia Villegas discuss how the STRIDE framework helps quantify the clinical value of diagnostics. They explore the dilemma of broad- versus narrow-spectrum antibiotic therapy, explain why mortality may not be the most relevant endpoint for evaluating rapid diagnostics, and discuss how timely diagnostic results can support antimicrobial stewardship, infection control, and AMR surveillance.</p>","author_name":"bioMérieux "}